Henry Schein

Henry Schein

Global healthcare product distributor and services

Customer Service Representative

Full-Time
No salary listed
Entry
Gillingham, UK
Hybrid

About the job

Requirements
  • A high standard of spoken and written English is required, together with basic numeracy.
  • Fast and accurate keyboard operation is required.
  • Knowledge of Windows and Microsoft Office systems and use of email is required.
Responsibilities
  • Communicate with customers by telephone, email, and other omnichannel channels, offering friendly, helpful, and effective solutions.
  • Listen carefully and ask questions to understand how to help customers.
  • Log call details quickly and accurately into a customer relationship management case file.
  • Answer high volumes of calls, provide first-touch resolution, or log issues for investigation and closure while providing customers with an update date.
  • Liaise collaboratively with internal departments, field teams, manufacturers, and external agencies to obtain information and resolve issues.
  • Communicate with external carrier companies to track deliveries, obtain proof of delivery, and arrange parcel collections for warehouse returns.
  • Process Adverse Event and Product Recall situations professionally, accurately, and promptly.
  • Provide COSHH sheets to customers on request.
  • Record and process small equipment repairs.
  • Process non-stock orders and raise credit notes.
  • Evaluate and prepare carrier insurance claims.
  • Provide customers with online support.
  • Provide information about the anticipated arrival of stock at the warehouse.
  • Support reporting functions to ensure personal and team targets are met.
  • Handle frontline telephone enquiries for the Customer Accounts Department.
  • Participate in special projects and perform other duties as required.
Desired Qualifications
  • Previous customer service experience.
  • Knowledge of Salesforce communication.
  • Knowledge of J D Edwards systems.
  • Knowledge of dental products.

About the company

Henry Schein is a global supplier of healthcare products and services. It operates in two segments: healthcare distribution, which provides dental and medical consumables, equipment, and laboratory products to dentists, physicians, and veterinarians; and technology and value-added services, which offers practice management software, e-commerce solutions, and financial services. The company works by supplying healthcare professionals with a broad range of products and by offering software, online tools, and financing options to run their practices more efficiently. Compared with competitors, Henry Schein combines a wide product catalog with software and financial services, creating a one-stop platform for practice needs across more than 30 countries, with a strong focus on North America. Its goal is to be a trusted partner for healthcare professionals by supporting their day-to-day operations and growth through integrated distribution, technology, and financing solutions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Town of Huntington, New York

Founded

1932

Get referred to Henry Schein

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 sales rose 6.7% to $3.5 billion, lifting full-year guidance.
  • US dental merchandise sales climbed 8.3%, with market-share gains in the United States and Canada.
  • Expanded credit facility to $1.25 billion through 2031 funds buybacks, acquisitions, and working capital.

What critics are saying

  • July 30, 2026 leadership exits removed COO Ettinger, CSO Mlotek, and supply-chain chief Mullins.
  • Dental consumables growth depends on price hikes and DSO demand, not durable procedure acceleration.
  • A failed 2026 restructuring would leave HSIC exposed to cheaper distributors and software-first competitors.

What makes Henry Schein unique

  • Henry Schein One serves 13,000 customers, and 90% of revenue is recurring.
  • Dentrix Ascend AI workflow and MCP platform deepen switching costs for dental practices.
  • One Schein unifies distribution, software, and private-label brands across office-based care.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

Paid Vacation

Paid Parental Leave

Short Term Disability

Health Savings Account/Flexible Spending Account

Education Benefits

Growth & Insights and Company News

Headcount

6 month growth

↑ 7%

1 year growth

↑ 7%

2 year growth

↑ 7%
TipRanks
Sep 22nd, 2026
Henry Schein expands credit facility to $1.25B, extends term to 2031

Henry Schein has amended and restated its revolving credit agreement, expanding aggregate commitments from $1 billion to $1.25 billion. The facility's termination date has been extended to 19 September 2031. The revised facility, arranged with a syndicate of major international banks, adjusts certain financial definitions and covenants. This provides the healthcare distribution company with greater flexibility in its capital structure. Henry Schein intends to use the enlarged credit facility for working capital and general corporate purposes. These include capital expenditures, share repurchases, refinancing existing debt, and funding potential acquisitions. The agreement includes customary representations, warranties, covenants, and events of default. The company supplies dental, medical, and animal health products to office-based practitioners and healthcare organisations in North America and international markets.

Yahoo Finance
Aug 31st, 2026
Henry Schein shares up 13% in Q2 as cost cuts and revenue growth support bullish outlook

MD Sass Concentrated Value Strategy highlighted Henry Schein as a notable contributor in its second-quarter 2026 investor letter. The healthcare solutions provider saw its shares appreciate 13% during the quarter. The asset management firm believes significant cost reductions combined with accelerating revenue growth should lead to material positive earnings revisions moving into the fourth quarter and 2027. MD Sass met with Henry Schein's new chief executive officer, Fred Lowery, and expects his distribution experience and operational approach to improve efficiencies, margins, and market share. The firm's estimates remain well above consensus over the next several years. Henry Schein closed at $89.52 per share on 28 August 2026, with a market capitalisation of $9.98 billion.

Yahoo Finance
Aug 13th, 2026
Henry Schein beats Q2 estimates with $3.46B revenue, raises full-year guidance on dental growth

Henry Schein reported second-quarter results that exceeded Wall Street expectations, with revenue of $3.46 billion versus analyst estimates of $3.37 billion and adjusted EPS of $1.27 versus $1.24 expected. The company attributed the performance to accelerating internal sales growth and robust gains in its global dental merchandise segment. CEO Frederick Lowery highlighted success in converting occasional buyers into regular customers and strong market share gains in the US and Canada. The company slightly raised its full-year adjusted EPS guidance to $5.34 at the midpoint. During the earnings call, analysts questioned the sustainability of US dental consumables growth and the timing of value creation benefits. CFO Ronald South indicated most operating income improvements from these initiatives would materialise in the second half of the year.

Yahoo Finance
Aug 4th, 2026
Henry Schein raises 2026 guidance after Q2 sales hit $3.5B on dental gains

Henry Schein reported second-quarter sales of $3.5 billion, up 6.7% year-over-year, driven by 4.6% internal local-currency growth and foreign exchange benefits. The healthcare distributor raised its full-year guidance following stronger-than-expected performance. GAAP net income rose to $94 million, or $0.82 per diluted share, from $86 million a year earlier. Non-GAAP earnings reached $1.27 per share, up 15.5% from $1.10 in the prior-year period. Operating margins expanded across all segments. GAAP operating margin increased 27 basis points to 4.94%, whilst non-GAAP operating margin grew 25 basis points to 7.21%. US dental merchandise sales climbed 8.3%, including 6.5% internal growth, with the company reporting market-share gains. Chief Executive Officer Fred Lowery attributed results to operational execution and early benefits from its value-creation programme.

Yahoo Finance
Jun 23rd, 2026
Henry Schein stock gains 9.4% over 52 weeks, trails Nasdaq's 33.3% surge

Henry Schein (HSIC), a $9 billion healthcare distribution company, has underperformed the Nasdaq Composite despite recent gains. The stock is up 5.7% over three months, trailing the Nasdaq's 19.2% rise during the same period. Year-to-date, HSIC has gained 4.1% compared to the Nasdaq's 12.6% advance. The Melville, New York-based company, which supplies dental, medical and laboratory products to over one million customers, reported stronger-than-expected first-quarter results on 5 May. Adjusted earnings per share of $1.32 beat analyst estimates of $1.20, whilst revenue of $3.4 billion exceeded forecasts of $3.3 billion. Despite softer medical segment demand from a milder flu season, strength in Home Solutions and technology offerings offset the impact. The company expects full-year adjusted EPS between $5.23 and $5.37.